The administration of U.S. President Donald Trump has announced it will defer $1.3 billion in Medicaid reimbursements to the state of California, accusing state authorities of failing to address fraud within the publicly funded healthcare program adequately.
Vice President JD Vance announced on Wednesday, May 13, saying the decision was part of a broader federal crackdown on alleged abuse involving taxpayer-funded healthcare services.
“We’re announcing that the federal government is deferring $1.3 billion in Medicaid reimbursements from the state of California, and the simple reason is because the state of California has not taken fraud very seriously,” Vance said.
Trump admin defers $1.3 billion in California medicaid funds
According to the vice president, the administration believes fraudulent practices within parts of the Medicaid system have affected both taxpayers and patients. He alleged that some healthcare providers had administered unnecessary treatments or issued unnecessary prescriptions to claim reimbursement.
“You have people who’ve been prescribed medications that they don’t even need,” Vance stated. “These fraudulent healthcare providers are getting rich by giving people medications they don’t even need.”
Also Read: Trump Declares War on Democratic Politicians Over Alleged “Massive Fraud”
He added that the administration viewed the issue not only as financial misconduct but also as a breach of trust between patients and healthcare providers.
The announcement marks the latest step in what the Trump administration has described as a nationwide “war on fraud,” an initiative President Trump formally introduced during his recent State of the Union address earlier in the year.
During the speech, Trump said his administration would intensify oversight of federal spending programs and named Vance to lead the anti-fraud effort.
Federal officials have characterized the California measure as a deferment rather than a permanent funding cut, meaning the withheld reimbursements could still be released if the state strengthens its anti-fraud systems and oversight procedures.
The administration has not publicly detailed which specific California Medicaid programs are under scrutiny or how the alleged fraud was identified. California authorities had not issued an immediate public response at the time of publication.
Minnesota funds
The move follows similar action taken earlier this year against Minnesota, where the administration suspended more than $250 million in Medicaid reimbursements pending investigations into alleged fraudulent activity across several healthcare support programs.
In Minnesota, officials said the investigations focused on 14 programs considered vulnerable to abuse, including autism support services, at-home rehabilitation care, night supervision services, after-school programs for autistic children, and non-emergency medical transportation.
Also Read: Trump Suspends Medicaid Millions to Minnesota Over Fraud Probe
Speaking alongside Mehmet Oz during the Minnesota announcement, Vance said healthcare providers in the state had already received payments from local authorities and that the federal government was withholding reimbursements to the state itself rather than cutting off patient services.
“The providers on the ground in Minnesota have actually already been paid,” Vance said at the time.
“What we’re doing is stopping the federal payments that will go to the state government until the state government takes its obligations seriously to stop the fraud.”
The administration also announced a nationwide pause on new Medicare subsidy approvals for suppliers of durable medical equipment, including products such as walkers and canes, while additional fraud reviews are conducted.
Why this matters
Medicaid, the joint federal-state healthcare program designed primarily for low-income Americans, remains one of the largest areas of public spending in the United States.
The program is jointly administered by the state and federal governments, with disputes over oversight, compliance, and reimbursement procedures frequently becoming points of political and legal tension between Washington and individual states.
The California deferment is likely to intensify debate over the balance of authority between federal agencies and state governments in managing healthcare programs, particularly as the Trump administration expands its enforcement campaign.
While the White House says the measures are necessary to protect taxpayer money and prevent abuse, state officials and healthcare advocates are expected to closely monitor whether the deferred funds ultimately affect service delivery, reimbursement timelines, or healthcare access for Medicaid recipients.
No timeline has yet been announced for when the deferred California reimbursements could be restored.
